ROBINUL FORTE Drug Patent Profile
✉ Email this page to a colleague
When do Robinul Forte patents expire, and when can generic versions of Robinul Forte launch?
Robinul Forte is a drug marketed by Casper Pharma Llc and is included in one NDA.
The generic ingredient in ROBINUL FORTE is glycopyrrolate. There are seventeen drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Robinul Forte
A generic version of ROBINUL FORTE was approved as glycopyrrolate by AM REGENT on July 23rd, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ROBINUL FORTE?
- What are the global sales for ROBINUL FORTE?
- What is Average Wholesale Price for ROBINUL FORTE?
Summary for ROBINUL FORTE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 113 |
| Clinical Trials: | 6 |
| Patent Applications: | 3,893 |
| Drug Prices: | Drug price information for ROBINUL FORTE |
| DailyMed Link: | ROBINUL FORTE at DailyMed |
Recent Clinical Trials for ROBINUL FORTE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| McGill University Health Center | N/A |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | N/A |
| University of Oulu | Phase 4 |
Pharmacology for ROBINUL FORTE
| Drug Class | Anticholinergic |
| Mechanism of Action | Cholinergic Antagonists |
Paragraph IV (Patent) Challenges for ROBINUL FORTE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| ROBINUL FORTE | Tablets | glycopyrrolate | 2 mg | 012827 | 1 | 2010-10-12 |
| ROBINUL FORTE | Tablets | glycopyrrolate | 1 mg | 012827 | 1 | 2009-08-14 |
US Patents and Regulatory Information for ROBINUL FORTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Casper Pharma Llc | ROBINUL FORTE | glycopyrrolate | TABLET;ORAL | 012827-002 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ROBINUL FORTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Casper Pharma Llc | ROBINUL FORTE | glycopyrrolate | TABLET;ORAL | 012827-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
